JSB Market Research : BIOMARKERS

Aark1

Description

Biomarkers Market research report focuses on the different types of biomarkers and their impact on various disease areas such as oncology (prostate, ovarian, breast and lung), neurology (stroke, brain tumor, neurodegenerative diseases), cardiology (coronary heart disease, heart failure, myocardial infarction), infectious diseases (GIT, respiratory tract infections) and other areas including metabolomic turmoil, arthritis, gynecology, oxidative stress, liver disease, pulmonary disease and aging, etc.
See Full Report: http://bit.ly/1yXK1oQ

Informations

• Publié par: richa21
• Publié le: 27 janvier 2015
• Nombre de lectures: 1
• Langue: English

Extrait

th Released On 27 January 2015

BIOMARKERS

BiomarkersMarket research report focuses on the different types of biomarkers and their impact on various disease areas such as oncology (prostate, ovarian, breast and lung), neurology (stroke, brain tumor, neurodegenerative diseases), cardiology (coronary heart disease, heart failure, myocardial infarction), infectious diseases (GIT, respiratory tract infections) and other areas including metabolomic turmoil, arthritis, gynecology, oxidative stress, liver disease, pulmonary disease and aging, etc. The study provides Global Biomarkers market size by the above disease areas and also by prominent biomarker identification technologies including imaging, genomics, proteomics, metabolomics, gene expression and other technologies comprising fluorescent indicators, lab-on-chip, nuclear magnetic resonance, mass spectrometry/liquid chromatography and nanobiotechnology. Compilation of Worldwide Patents and Research related to Biomarkers is also provided. Biomarkers Market offers market values for global geographic regions including North America, Europe, Asia-Pacific and Rest of World.

Browse complete Report on: http://www.jsbmarketresearch.com/healthcare-medical/r-biomarkers-68420

JSB Market Research Pvt. Ltd. Email [e-mail] Tel No- 91 2241236650 / +91 - 998 729 5242 Published by-http:/www.jsbmarketresearch.com/

Table of Contents

1. SCOPE AND METHODOLOGY 2. REPORT SYNOPSIS 2.1 Introduction 2.2 Segmentation of Biomarkers Exhibit 1. Segmentation of Global Biomarkers Market by Therapeutic Area and Identification Technology Identification Technologies Imaging Genomics Proteomics Metabolomics Gene Expression Therapeutic Areas Oncology Cardiology Neurology Infectious Diseases Exhibit 2. Segmentation by Therapeutic Area for Oncology, Cardiology, Neurology, and Infectious Diseases 2.3 Global Biomarkers Market Exhibit 3. Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Billion (Graphical Representation Included) Exhibit 4. List of Global Major Biomarkers Companies 3. MARKET DYNAMICS 3.1 Global Market Overview 3.2 Global Biomarkers Market Exhibit 5. Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 6. Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.3 North American Biomarkers Market

JSB Market Research Pvt. Ltd. Email [e-mail] Tel No- 91 2241236650 / +91 - 998 729 5242 Published by-http:/www.jsbmarketresearch.com/

Exhibit 7. Biomarkers - North American Market Estimations & Predictions (2005 -2020) in US$ Million for United States and Canada (Graphical Representation Included) Exhibit 8. Biomarkers - North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included) 3.3 (I) United States Biomarkers Market 3.3 (II) Canadian Biomarkers Market Exhibit 9. List of North American Biomarkers Companies 3.4 European Biomarkers Market Exhibit 10. Biomarkers - European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 11. Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) 3.4 (I) German Biomarkers Market 3.4 (II) United Kingdom Biomarkers Market 3.4 (III) Italian Biomarkers Market 3.4 (IV) French Biomarkers Market 3.4 (V) Spanish Biomarkers Market 3.4 (VI) Swiss Biomarkers Market 3.4 (VII) Belgian Biomarkers Market 3.4 (VIII) Swedish Biomarkers Market 3.4 (IX) Russian Biomarkers Market Exhibit 12. List of European Biomarkers Companies 3.5 Asia-Pacific Biomarkers Market Exhibit 13. Biomarkers - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 14. Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.5 (I) Japanese Biomarkers Market 3.5 (II) Chinese Biomarkers Market 3.5 (III) Indian Biomarkers Market 3.5 (IV) Australian Biomarkers Market 3.5 (V) South Korean Biomarkers Market Exhibit 15. List of Asia-Pacific Biomarkers Companies

JSB Market Research Pvt. Ltd. Email [e-mail] Tel No- 91 2241236650 / +91 - 998 729 5242 Published by-http:/www.jsbmarketresearch.com/

3.6 Rest of World Biomarkers Market Exhibit 16. Biomarkers - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 17. Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.6 (I) Israeli Biomarkers Market 3.6 (II) South African Biomarkers Market 3.6 (III) Brazilian Biomarkers Market Exhibit 18. List of Rest of World Biomarkers Companies 3.7 Market Trends What are Pharma Companies Looking For in Biomarkers? Biomarkers - An Emerging Trend in Pharma Industry Innovative Biomarker Discovery Methods Aid in Drug Development Stages Biomarkers Becoming Important in Developing Better Drugs Pharma Companies Investing Huge Amounts in Biomarkers Discovery 3.8 Company Profiles - Major Players in Biomarker Market Abbott Diagnostics (USA) Affymetrix, Inc. (USA) Agendia BV ((The Netherlands)) Agilent Technologies, Inc. (USA) AltheaDx, Inc. (USA) More…. 3.9 Major Activities in Biomarker Industry Exonhit and Pfizer Enters into Research Agreement for AD Biomarkers Identification IVD Acquisition Corporation Takes Over Immucor TcLand Expression Strategic Partnership for Development of Novel RA Biomarkers Stemina Biomarker and Pioneer Hi-Bred Sign Research Agreement Astellas Pharma Completes Acquisition of OSI Pharmaceuticals OriGene and ISB alliance for SRM/MRM database Duke Associates with LabCorp to Develop a Joint Venture Company, the Biomarker Factory Thermo Fisher Enters into a Collaboration Agreement with LCP for Improved Biomarker Discovery and Assay Development Process… Axela Associates with Salomao & Zoppi and CRIA Opportunities

JSB Market Research Pvt. Ltd. Email [e-mail] Tel No- 91 2241236650 / +91 - 998 729 5242 Published by-http:/www.jsbmarketresearch.com/

SQI Diagnostics Enters into a Development Deal with Silliker for Marketing of Botulism Toxin Panel PROOF Centre Enters into Partnership Agreement with Luminex Celerion Completes Acquisition of MDS Pharma Services Early Stage Clinical Development Operations Philips Signs a MoU with Definiens for Co-Developing and Marketing Solutions for Digital Pathology Ricerca Biosciences LLC Purchases MDS Pharma Services PAREXEL International and Proteome Sciences Forms an Alliance for Biomarker Development Biocartis Acquires Automated DNA/RNA Molecular Diagnostic Testing Platform of Philips More…. 3.10 Major Product Innovations/Launches in Biomarker Industry AB SCIEX Expands Eksigent Chip Column Family for Nano and Micro LC Proteomics Analysis WaferGen Biosystems Supplies SmartChip Real-Time PCR System to Kyoto University for Enhancing the Research on Regenerative Tissue C-Path Becomes First Ever Biomarker Panel to be Approved by Japanese Regulators Tethys Inc., Receives US Patent for the Outstanding PreDx™ Diabetes Risk Score Test Millipore Launches Test Kits for Human Kidney Damage TGen Piloted Group Led Studies Identify Genetic Links to Kidney Disease WaferGen Biosystems Inc., Markets Two of Gene Expression Profiling Panels Designed for SmartChip Real-Time PCR System Cancer Prevention and Research Institute of Texas Awards Funds to Rules-Based Medicine Quintiles Launches Wide-Ranging Suite of PI3K Biomarker Assays BioMarker Strategies Obtains Funds of US$1 Million from NCI StemTroniX and Power3 Submit Patent Application for Stem Cell Protein Biomarkers Pronota Achieves Base of Next Generation Sequencing Application for Identification and Quantification of Proteins bioMérieux and GlaxoSmithKline Enter into Alliance for the Development of Molecular Theranostic Test More….. 3.11 Therapeutic Area Analysis

JSB Market Research Pvt. Ltd. Email [e-mail] Tel No- 91 2241236650 / +91 - 998 729 5242 Published by-http:/www.jsbmarketresearch.com/

Exhibit 19. Biomarkers by Therapeutic Area - Global Market Estimations and Predictions (2005-2020) in US$ Million for Oncology, Cardiology, Neurology, Infectious Disease, Genetic Disorders & Other (Graphical Representation Included) Exhibit 20. Biomarkers - Global Market Shares (2010, 2015 & 2020) for Oncology, Cardiology, Neurology, Infectious Disease, Genetic Disorders & Other (Graphical Representation Included) 3.11.1 ONCOLOGY 3.11.1.1 Global Oncology Biomarkers Market Exhibit 21. Biomarkers in Oncology - Global Market Estimations and Predictions (2005- 2020) in US$ Million for Prostate Cancer, Ovarian Cancer, Breast Cancer, Lung Cancer and Other (Graphical Representation Included) Exhibit 22. Biomarkers in Oncology - Global Market Shares (2010, 2015 & 2020) for Prostate Cancer, Ovarian Cancer, Breast Cancer, Lung Cancer and Other (Graphical Representation Included) Exhibit 23. Biomarkers in Oncology - Global Market Estimations and Predictions (2005- 2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 24. Biomarkers in Oncology - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.1.2 North American Oncology Biomarkers Market Exhibit 25. Biomarkers in Oncology - North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 26. Biomarkers in Oncology - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.1.2 (I) United States Oncology Biomarkers Market 3.11.1.2 (II) Canadian Oncology Biomarkers Market Exhibit 27. List of North American Oncology Biomarkers Companies 3.11.1.3 European Oncology Biomarkers Market Exhibit 28. Biomarkers in Oncology - European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 29. Biomarkers in Oncology - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)

JSB Market Research Pvt. Ltd. Email [e-mail] Tel No- 91 2241236650 / +91 - 998 729 5242 Published by-http:/www.jsbmarketresearch.com/

3.11.1.3 (I) German Oncology Biomarkers Market 3.11.1.3 (II) United Kingdom Oncology Biomarkers Market 3.11.1.3 (III) Italian Oncology Biomarkers Market 3.11.1.3 (IV) French Oncology Biomarkers Market 3.11.1.3 (V) Spanish Oncology Biomarkers Market 3.11.1.3 (VI) Swiss Oncology Biomarkers Market 3.11.1.3 (VII) Belgian Oncology Biomarkers Market 3.11.1.3 (VIII) Swedish Oncology Biomarkers Market 3.11.1.3 (IX) Russian Oncology Biomarkers Market Exhibit 30. List of European Oncology Biomarkers Companies 3.11.1.4 Asia-Pacific Oncology Biomarkers Market Exhibit 31. Biomarkers in Oncology - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia- Pacific (Graphical Representation Included) Exhibit 32. Biomarkers in Oncology– Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.1.4 (I) Japanese Oncology Biomarkers Market 3.11.1.4 (II) Chinese Oncology Biomarkers Market 3.11.1.4 (III) Indian Oncology Biomarkers Market 3.11.1.4 (IV) Australian Oncology Biomarkers Market 3.11.1.4 (V) South Korean Oncology Biomarkers Market Exhibit 33. List of Asia-Pacific Oncology Biomarkers Companies 3.11.1.5 Rest of World Oncology Biomarkers Market Exhibit 34. Biomarkers in Oncology - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 35. Biomarkers in Oncology - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.1.5 (I) Israeli Oncology Biomarkers Market 3.11.1.5 (II) South African Oncology Biomarkers Market 3.11.1.5 (III) Brazilian Oncology Biomarkers Market Exhibit 36. List of Rest of World Oncology Biomarkers Companies 3.11.1.A PROSTATE CANCER 3.11.1.A .1 Global Prostate Cancer Biomarkers Market

JSB Market Research Pvt. Ltd. Email [e-mail] Tel No- 91 2241236650 / +91 - 998 729 5242 Published by-http:/www.jsbmarketresearch.com/

Exhibit 37. Prostate Cancer Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 38. Prostate Cancer Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.1.A .2 North American Prostate Cancer Biomarkers Market Exhibit 39. Prostate Cancer Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 40. Prostate Cancer Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.1.A .2 (I) United States Prostate Cancer Biomarkers Market 3.11.1.A .2 (II) Canadian Prostate Cancer Biomarkers Market Exhibit 41. List of North American Prostate Cancer Biomarkers Companies 3.11.1.A .3 European Prostate Cancer Biomarkers Market Exhibit 42. Prostate Cancer Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 43. Prostate Cancer Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.11.1.A .3 (I) German Prostate Cancer Biomarkers Market 3.11.1.A .3 (II) United Kingdom Prostate Cancer Biomarkers Market 3.11.1.A .3 (III) Italian Prostate Cancer Biomarkers Market 3.11.1.A .3 (IV) French Prostate Cancer Biomarkers Market 3.11.1.A .3 (V) Spanish Prostate Cancer Biomarkers Market 3.11.1.A .3 (VI) Swiss Prostate Cancer Biomarkers Market 3.11.1.A .3 (VII) Belgian Prostate Cancer Biomarkers Market 3.11.1.A .3 (VIII) Swedish Prostate Cancer Biomarkers Market 3.11.1.A .3 (IX) Russian Prostate Cancer Biomarkers Market Exhibit 44. List of European Prostate Cancer Biomarkers Companies 3.11.1.A .4 Asia-Pacific Prostate Cancer Biomarkers Market Exhibit 45. Prostate Cancer Biomarkers - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia- Pacific (Graphical Representation Included)

JSB Market Research Pvt. Ltd. Email [e-mail] Tel No- 91 2241236650 / +91 - 998 729 5242 Published by-http:/www.jsbmarketresearch.com/

Exhibit 46. Prostate Cancer Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.1.A .4 (I) Japanese Prostate Cancer Biomarkers Market 3.11.1.A .4 (II) Chinese Prostate Cancer Biomarkers Market 3.11.1.A .4 (III) Indian Prostate Cancer Biomarkers Market 3.11.1.A .4 (IV) Australian Prostate Cancer Biomarkers Market 3.11.1.A .4 (V) South Korean Prostate Cancer Biomarkers Market Exhibit 47. List of Asia-Pacific Prostate Cancer Biomarkers Companies 3.11.1.A .5 Rest of World Prostate Cancer Biomarkers Market Exhibit 48. Prostate Cancer Biomarkers - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 49. Prostate Cancer Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.1.A .5 (I) Israeli Prostate Cancer Biomarkers Market 3.11.1.A .5 (II) South African Prostate Cancer Biomarkers Market 3.11.1.A .5 (III) Brazilian Prostate Cancer Biomarkers Market 3.11.1. B OVARIAN CANCER 3.11.1.B .1 Global Ovarian Cancer Biomarkers Market Exhibit 50. Ovarian Cancer Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 51. Ovarian Cancer Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.1. B .2 North American Ovarian Cancer Biomarkers Market Exhibit 52. Ovarian Cancer Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 53. Ovarian Cancer Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.1. B .2 (I) United States Ovarian Cancer Biomarkers Market 3.11.1. B .2 (II) Canadian Ovarian Cancer Biomarkers Market

JSB Market Research Pvt. Ltd. Email [e-mail] Tel No- 91 2241236650 / +91 - 998 729 5242 Published by-http:/www.jsbmarketresearch.com/

Exhibit 54. List of North American Ovarian Cancer Biomarkers Companies 3.11.1. B .3 European Ovarian Cancer Biomarkers Market Exhibit 55. Ovarian Cancer Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 56. Ovarian Cancer Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.11.1. B .3 (I) German Ovarian Cancer Biomarkers Market 3.11.1. B .3 (II) United Kingdom Ovarian Cancer Biomarkers Market 3.11.1. B .3 (III) Italian Ovarian Cancer Biomarkers Market 3.11.1. B .3 (IV) French Ovarian Cancer Biomarkers Market 3.11.1. B .3 (V) Spanish Ovarian Cancer Biomarkers Market 3.11.1. B .3 (VI) Swiss Ovarian Cancer Biomarkers Market 3.11.1. B .3 (VII) Belgian Ovarian Cancer Biomarkers Market 3.11.1. B .3 (VIII) Swedish Ovarian Cancer Biomarkers Market 3.11.1. B .3 (IX) Russian Ovarian Cancer Biomarkers Market Exhibit 57. List of European Ovarian Cancer Biomarkers Companies 3.11.1. B .4 Asia-Pacific Ovarian Cancer Biomarkers Market Exhibit 58. Ovarian Cancer Biomarkers - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia- Pacific (Graphical Representation Included) Exhibit 59. Ovarian Cancer Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.1. B .4 (I) Japanese Ovarian Cancer Biomarkers Market 3.11.1. B .4 (II) Chinese Ovarian Cancer Biomarkers Market 3.11.1. B .4 (III) Indian Ovarian Cancer Biomarkers Market 3.11.1. B .4 (IV) Australian Ovarian Cancer Biomarkers Market 3.11.1. B .4 (V) South Korean Ovarian Cancer Biomarkers Market Exhibit 60. List of Asia-Pacific Ovarian Cancer Biomarkers Companies 3.11.1. B .5 Rest of World Ovarian Cancer Biomarkers Market Exhibit 61. Ovarian Cancer Biomarkers - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)

JSB Market Research Pvt. Ltd. Email [e-mail] Tel No- 91 2241236650 / +91 - 998 729 5242 Published by-http:/www.jsbmarketresearch.com/

Exhibit 62. Ovarian Cancer Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.1. B .5 (I) Israeli Ovarian Cancer Biomarkers Market 3.11.1. B .5 (II) South African Ovarian Cancer Biomarkers Market 3.11.1. B .5 (III) Brazilian Ovarian Cancer Biomarkers Market Exhibit 63. List of Rest of World Ovarian Cancer Biomarkers Companies 3.11.1. C BREAST CANCER 3.11.1. C.1 Global Breast Cancer Biomarkers Market Exhibit 64. Breast Cancer Biomarkers - Global Market Estimations and Predictions (2005- 2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 65. Breast Cancer Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.1. C.2 North American Breast Cancer Biomarkers Market Exhibit 66. Breast Cancer Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 67. Breast Cancer Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.1. C.2 (I) United States Breast Cancer Biomarkers Market 3.11.1. C.2 (II) Canadian Breast Cancer Biomarkers Market Exhibit 68. List of North American Breast Cancer Biomarkers Companies 3.11.1. C.3 European Breast Cancer Biomarkers Market Exhibit 69. Breast Cancer Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 70. Breast Cancer Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.11.1. C.3 (I) German Breast Cancer Biomarkers Market 3.11.1. C.3 (II) United Kingdom Breast Cancer Biomarkers Market 3.11.1. C.3 (III) Italian Breast Cancer Biomarkers Market 3.11.1. C.3 (IV) French Breast Cancer Biomarkers Market 3.11.1. C.3 (V) Spanish Breast Cancer Biomarkers Market

JSB Market Research Pvt. Ltd. Email [e-mail] Tel No- 91 2241236650 / +91 - 998 729 5242 Published by-http:/www.jsbmarketresearch.com/